Increased levels of total tau protein in the cerebrospinal fluid in Huntington’s disease
Radu Constantinescu(Sahlgrenska University Hospital), Karl Kieburtz(Beth Israel Deaconess Medical Center), Lars Rosengren(Sahlgrenska University Hospital), Megan Romer(University of Rochester), Henrik Zetterberg(University of Wisconsin–Madison)
Cited by 42
Related Papers
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k
Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen
|The Lancet Neurology|2009|912
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
|JAMA Neurology|2021|627
Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report
|Nature Medicine|2019|606
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease
|Alzheimer s & Dementia|2022|589